Assessment of thirteen-week subchronic oral toxicity of cyadox in Beagle dogs

Regulatory Toxicology and Pharmacology

Volumn 73, Issue 2, 2015, Pages 652-659

  Wang, Xu ^a   Zhou, Wen ^b   Ihsan, Awais ^d   Chen, Dongmei ^b   Cheng, Guyue ^b   Hao, Haihong ^c   Liu, Zhenli ^c   Wang, Yulian ^c   Yuan, Zonghui ^a,b,c  

^a MOA Key Laboratory of Food Safety Evaluation   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^c Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety   (China)

^d Department of Biosciences COMSATS Institute of Information Technology ^*  (Pakistan)

Author keywords

Beagle dogs; Cyadox; Quinoxaline; Subchronic toxicity; Toxicity

Indexed keywords

CIADOX; POTASSIUM; QUINOXALINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BEAGLE; CONTROLLED STUDY; DRUG EFFECT; EXPOSURE; FEEDING; FEMALE; MALE; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; TOXICITY TESTING; ANIMAL; BODY WEIGHT; DOG; DRUG EFFECTS; EATING; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PHYSIOLOGY; PROCEDURES; TIME FACTOR;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; DOGS; EATING; FEMALE; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; QUINOXALINES; TIME FACTORS; TOXICITY TESTS, SUBCHRONIC;

EID: 84945269300     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.09.023     Document Type: Article

References (38)

1. Ding M.X., Wang Y.L., Zhu H.L., Yuan Z.H. Effects of cyadox and olaquindox on intestinal mucosal immunity and on fecal shedding of Escherichia coli in piglets. J. Animal Sci. 2006, 84:2367-2373.
2. Ding M.X., Yuan Z.H., Wang Y.L., Zhu H.L., Fan S.X. Olaquindox and cyadox stimulate growth and decrease intestinal mucosal immunity of piglets orally inoculated with Escherichia coli. J. Animal Physiol. Animal Nutr. Berl. 2006, 90:238-243.
3. Ding H., Liu Y., Zeng Z., Si H., Liu K., Liu Y., Yang F., Li Y., Zeng D. Pharmacokinetics of mequindox and one of its major metabolites in chickens after intravenous, intramuscular and oral administration. Res. Vet. Sci. 2012, 93(1):374-377.
4. Fang G., He Q., Zhou S., Wang D., Zhang Y., Yuan Z. Subchronic oral toxicity study with cyadox in Wistar rats. Food Chem. Toxicol. 2006, 44:36-41.
5. FDA Subchronic Toxicity Studies with Non-rodents. Toxicological Principles for the Safety Assessment of Food Ingredients Redbook 2000 2003, http://www.cfsan.fda.gov/%7Eredbook/redIVC4b.html.
6. Huang X.J., Ihsan A., Wang X., Dai M.H., Wang Y.L., Su S.J., Xue X.J., Yuan Z.H. Long-term dose-dependent response of Mequindox on aldosterone, corticosterone and five steroidogenic enzyme mRNAs in the adrenal of male rats. Toxicol. Lett. 2009, 191:167-173.
7. Huang X.J., Wang X., Ihsan A., Liu Q., Xue X.J., Su S.J., Yang C.H., Zhou W., Yuan Z.H. Interactions of NADPH oxidase, renin-angiotensin-aldosterone system and reactive oxygen species in mequindox-mediated aldosterone secretion in Wistar rats. Toxicol. Lett. 2010, 198:112-118.
8. Huang X.J., Zhang H.H., Wang X., Huang L.L., Zhang L.Y., Yan C.X., Liu Y., Yuan Z.H. ROS mediated cytotoxicity of porcine adrenocortical cells induced by QdNOs derivatives in vitro. Chem. Biol. Interact. 2010, 185:227-234.
9. Ihsan A., Wang X., Huang X.J., Liu Y., Liu Q., Zhou W., Yuan Z.H. Acute and subchronic toxicological evaluation of Mequindox in Wistar rats. Regul. Toxicol. Pharmacol. 2010, 57:307-314.
10. Ihsan A., Wang X., Tu H.G., Zhang W., Dai M.H., Peng D.P., Wang Y.L., Huang L.L., Chen D.M., Mannan S., Tao Y.F., Liu Z.L., Yuan Z.H. Genotoxicity evaluation of Mequindox in different short-term tests. Food Chem. Toxicol. 2013, 51:330-336.
11. Ihsan A., Wang X., Zhang W., Tu H., Wang Y., Huang L., Iqbal Z., Cheng G., Pan Y., Liu Z., Tan Z., Zhang Y., Yuan Z. Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo. Food Chem. Toxicol. 2013, 59:207-214.
12. Li G., Yang F., He L., Ding H., Sun N., Liu Y., Liu Y., Shan Q., Li Y., Zeng Z. Pharmacokinetics of mequindox and its metabolites in rats after intravenous and oral administration. Res. Vet. Sci. 2012, 93(3):1380-1386.
13. Liu Z., Huang L., Dai M., Chen D., Wang Y., Tao Y., Yuan Z. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2008, 22:1009-1016.
14. Liu Z., Huang L., Dai M., Chen D., Tao Y., Wang Y., Yuan Z. Metabolism of cyadox in rat, chicken and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23:2026-2034.
15. Liu Z.Y., Huang L.L., Chen D.M., Dai M.H., Tao Y.F., Wang Y.L., Yuan Z.H. Application of electrospray ionization hybrid ion trap/time-of-flight mass spectrometry in the rapid characterization of quinocetone metabolites formed in vitro. Anal. Bioanal. Chem. 2010, 396:1259-1271.
16. Michael J.D. Handbook of Toxicology 2002, 66-72. Taylor & Francis, Boca Raton. second ed.
17. Nastuneak J., Klouch F., Vanova L., Dvorak M., Sevick B. Three month toxicity to laboratory Norway rats: cyadox compared with olaquindox. Biol. Chem. Vet. (Prague) 1986, 22:367-380.
18. Nastuneak J., Dvorak M., Klouch F., Vanova L. Cyadox toxicity studies over twelve months on laboratory rats. J. Biol. Chem. 1987, 23:549-555.
19. NRC Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
20. OECD Guidelines for Testing of Chemicals No. 409, Repeat Dose 90-day Oral Toxicity Study in Non-rodents, Adopted September 1998.
21. Qiu Y. Pharmacokinetics and Residue Depletion of Cyadox in Swine 2003, 3-4. Huazhong Agriculture University, (Doctoral dissertation).
22. Sevcik B. Research of harmless and safety of application of the growth promoter cyadox. Workshop 1986, 1:93.
23. Shin J.W., Park H.J., Kwon M., Son C.G. Scientific evaluation of the chronic toxicity of the herbal medicine CGX in beagle dogs. Food Chem. Toxicol. 2010, 48:743-749.
24. Vicente E., Perez-Silanes S., Lima L.M., Ancizu S., Burguete A., Solano B., Villar R., Aldana I., Monge A. Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides. Bioorg. Med. Chem. 2009, 17:385-389.
25. VICH Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Repeat-dose (90 Days)Toxicity Testing & VICH GL 31, 2002 2002, http://www.vichsec.org/pdf/05_2004/GL31_st7-Rev.pdf.
26. VICH Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Testing & VICH GL 33 2004, http://www.vichsec.org/pdf/05_2004/GL33_st7-Rev.pdf.
27. Wang Y., Yuan Z., Zhu H., Ding M., Fan S. Effect of cyadox on growth and nutrient digestibility in weanling pigs. South Afr. J. Animal Sci. 2005, 35:117-125.
28. Wang M., Yao J., Chen J.Y., Bai W.X., Mei S.Y., Pan W.N., Pan Y.Y., Yu F.L. A subchronic intravenous toxicity study of magnesium fructose-1,6-diphosphate in beagle dogs. Basic Clin. Pharmacol. Toxicol. 2009, 104:93-100.
29. Wang X., Zhang W., Wang Y., Peng D., Ihsan A., Huang X., Huang L., Liu Z., Dai M., Zhou W., Yuan Z.H. Acute and sub-chronic oral toxicological evaluations of quinocetone in Wistar rats. Regul. Toxicol. Pharmacol. 2010, 58:421-427.
30. Wang X., Fang G.J., Wang Y.L., Ihsan A., Huang L.L., Zhou W., Liu Z.L., Yuan Z.H. Two generation reproduction and teratogenicity studies of feeding cyadox in Wistar rats. Food Chem. Toxicol. 2011, 49:1068-1079.
31. Wang X., He Q.H., Wang Y.L., Ihsan A., Huang L.L., Zhou W., Su S.J., Liu Z.L., Yuan Z.H. A chronic toxicity study of cyadox in Wistar rats. Regul. Toxicol. Pharmacol. 2011, 59:324-333.
32. WHO Toxicological Evaluation of Certain Veterinary Drug Residues in Food. Olaquindox 1991, WHO Food Additives Series, No. 27, on INCHEM.
33. WHO Toxicological Evaluation of Certain Veterinary Drug Residues in Food. Carbadox 1991, WHO Food Additives Series, No. 27, No. 700 on INCHEM.
34. WHO Toxicological Evaluation of Certain Veterinary Drug Residues in Food 1991, WHO Food Additives Series, No. 27, No. 694-705 on INCHEM.
35. Yoshimura H. Teratogenic assessment of carbadox in rats. Toxicol. Lett. 2002, 129(1-2):115-118.
36. Zhang G., He L., Yan D., Wang Y., Fang B. Preliminary study on metabolism and pharmacokinetics of quinocetone in chickens. Prog. Vet. Med. 2011, 32(6):64-67.
37. Zhang H., Wang X., Huang L., Pan Y., Li J., Chen D., Cheng G., Hao H., Tao Y., Liu Z., Yuan Z. Deoxidation rates play a critical role in DNA damage mediated by important synthetic drugs, quinoxaline 1,4-dioxides. Chem. Res. Toxicol. 2015, 28:470-481.
38. Zhu Z., Chen Z., Feng Q. Studies on pharmacokinetics and tissue concentration of olaquindox in chickens. Chin. J. Animal Vet. Sci. 1993, 24(3):259-264.